The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
7.90
+0.03 (0.34%)
At close: Nov 4, 2025, 4:00 PM EST
7.89
-0.01 (-0.09%)
After-hours: Nov 4, 2025, 4:10 PM EST
The Joint Revenue
The Joint had revenue of $13.27M in the quarter ending June 30, 2025, with 5.24% growth. This brings the company's revenue in the last twelve months to $53.45M, up 277.36% year-over-year. In the year 2024, The Joint had annual revenue of $51.90M with 10.47% growth.
Revenue (ttm)
$53.45M
Revenue Growth
+277.36%
P/S Ratio
2.22
Revenue / Employee
$72,622
Employees
736
Market Cap
121.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.90M | 4.92M | 10.47% |
| Dec 31, 2023 | 46.98M | -54.27M | -53.60% |
| Dec 31, 2022 | 101.25M | 21.24M | 26.55% |
| Dec 31, 2021 | 80.01M | 21.33M | 36.34% |
| Dec 31, 2020 | 58.68M | 10.23M | 21.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
JYNT News
- 4 weeks ago - The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List - PRNewsWire
- 4 weeks ago - The Joint Chiropractic Debuts in Delaware - PRNewsWire
- 5 weeks ago - The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer - GlobeNewsWire
- 3 months ago - The Joint Corp. (JYNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges - GlobeNewsWire
- 3 months ago - The Joint Corp. to Host Conference Call on Thursday, August 7th to Discuss Second Quarter 2025 Results - GlobeNewsWire
- 4 months ago - The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region - GlobeNewsWire
- 4 months ago - The Joint Chiropractic Launches Official Mobile App on iOS and Android - PRNewsWire